Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
28.43
-0.04 (-0.14%)
At close: Apr 28, 2026, 4:00 PM EDT
28.42
-0.01 (-0.04%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.87 billion as of April 28, 2026. Its market cap has increased by 19.36% in one year.
Market Cap
1.87B
Enterprise Value
-1.63B
1-Year Change
19.36%
Ranking
Category
Stock Price
$28.43
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $1.87B, an increase of 0.39%. That is a compound annual growth rate of 0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.88B | -12.93% |
| Dec 31, 2025 | 2.15B | 18.91% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 1.99B |
| Capricor Therapeutics | 1.99B |
| AnaptysBio | 1.90B |
| Inhibrx Biosciences | 1.89B |
| Pharvaris | 1.87B |
| Taysha Gene Therapies | 1.84B |
| Recursion Pharmaceuticals | 1.84B |
| Syndax Pharmaceuticals | 1.84B |